SpecStream

Data / Form D filings / Quiver Holdings Inc.

Quiver Holdings Inc.: Form D filing

Quiver Holdings Inc., a biotechnology company in Cambridge, MA, filed a Form D with the SEC in 2026. The latest, on October 21, 2026, reports $3 million sold of an offering with no set size to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Get filings like this oneWeekly RSS feed

Company details from the filing

Address
150 CAMBRIDGEPARK DRIVE 5th Floor, Cambridge, MA, 02140
Phone
(617) 396-3611
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2160800

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 21New noticeIndefinite$3,005,0004Oct 8sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Graham T DempseyExecutive OfficerChief Executive Officer
David LiederbachExecutive OfficerPresident
David MarguliesExecutive Officer, DirectorTreasurer and Vice President
Paul RomaExecutive Officer, DirectorSecretary; Chairman of the Board
Jonathan FlemingDirector
Janet FouttyDirector
Paul BlackDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Oct 19 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Quiver Holdings Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.